Valeant expects antitrust waiting period for Salix buy to expire March 16
MLex Summary: Valeant Pharmaceuticals International said it expects the waiting period under the Hart-Scott-Rodino Act for its proposed acquisition of Salix Pharmaceuticals to expire March 16, according to a filing with...To view the full article, register now.
Already a subscriber? Click here to view full article